Search by Drug Name or NDC

    NDC 00536-1021-07 Peptic Relief 262 mg/1 Details

    Peptic Relief 262 mg/1

    Peptic Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Rugby Laboratories. The primary component is BISMUTH SUBSALICYLATE.

    Product Information

    NDC 00536-1021
    Product ID 0536-1021_429ee2d1-2c5c-4967-bf7d-0e1e8ebd2768
    Associated GPIs 47300010000507
    GCN Sequence Number 002860
    GCN Sequence Number Description bismuth subsalicylate TAB CHEW 262 MG ORAL
    HIC3 D6D
    HIC3 Description ANTIDIARRHEALS
    GCN 08420
    HICL Sequence Number 001246
    HICL Sequence Number Description BISMUTH SUBSALICYLATE
    Brand/Generic Generic
    Proprietary Name Peptic Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Peptic Relief
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 262
    Active Ingredient Units mg/1
    Substance Name BISMUTH SUBSALICYLATE
    Labeler Name Rugby Laboratories
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part335
    Listing Certified Through 2024-12-31

    Package

    NDC 00536-1021-07 (00536102107)

    NDC Package Code 0536-1021-07
    Billing NDC 00536102107
    Package 30 TABLET in 1 BOTTLE (0536-1021-07)
    Marketing Start Date 2014-02-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.0759
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description PEPTIC RELIEF 262 MG CHEW TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 713a580e-9ddb-44cd-8989-7411b7fd647c Details

    Revised: 1/2022